{"id":"W4313489278","doi":"10.1007/s00415-022-11517-w","title":"Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)","year":2023,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Myasthenia gravis; Medicine; Quality of life (healthcare); Placebo; Neurology; Visual analogue scale; Physical therapy; Neuroradiology; Clinical trial; Disease; Randomized controlled trial; Internal medicine; Pediatrics; Pathology; Alternative medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512286,0.001338975,0.002287953,0.0003798521,0.000314608,0.0006594455,0.000607604,0.001161445,0.002906922],"category_scores_gemma":[0.0007657614,0.0003339413,0.001675384,0.0003154252,0.0009432063,0.0006675425,0.0002641328,0.001943781,0.0003472097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004205237,"about_ca_system_score_gemma":0.0005415553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000874212,"about_ca_topic_score_gemma":0.002484781,"domain_scores_codex":[0.9996461,0.0001481503,0.0000279684,0.00005516285,0.00004589843,0.00007667563],"domain_scores_gemma":[0.9996555,0.00008643972,0.0001025338,0.00003265913,0.00002386453,0.00009914966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8546224,0.0287211,0.002270832,0.001789821,0.003213594,0.0002294157,0.0001599446,0.0006080757,0.03142556,0.000127754,0.001774542,0.07505693],"study_design_scores_gemma":[0.8170144,0.1639197,0.01611856,0.00004624807,0.0008478893,0.00009482259,0.0000343008,0.0003040043,0.0009097531,0.0001007078,0.0005820707,0.00002743718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926685,0.003512714,0.0003142628,0.0002954671,0.0001546168,0.001378147,0.0006009958,0.0001535003,0.0009217114],"genre_scores_gemma":[0.9914536,0.002579578,0.0009330281,0.001029404,0.000285673,0.00161999,0.0008537788,0.00002337527,0.001221546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002906922,"threshold_uncertainty_score":0.009724617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07156943883593164,"score_gpt":0.3675229443199784,"score_spread":0.2959535054840468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}